BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35860588)

  • 1. Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.
    Zhang J; Yuan X; Wang Y; Liu J; Li Z; Li S; Liu Y; Gong X; Sun Y; Wu W; Sun L; Du S; Wang T
    Front Oncol; 2022; 12():893132. PubMed ID: 35860588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas.
    Lee C; Lee J; Choi SA; Kim SK; Wang KC; Park SH; Kim SH; Lee JY; Phi JH
    BMC Cancer; 2018 May; 18(1):535. PubMed ID: 29739450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma.
    Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q
    Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages in SHH subgroup of medulloblastomas.
    Margol AS; Robison NJ; Gnanachandran J; Hung LT; Kennedy RJ; Vali M; Dhall G; Finlay JL; Erdreich-Epstein A; Krieger MD; Drissi R; Fouladi M; Gilles FH; Judkins AR; Sposto R; Asgharzadeh S
    Clin Cancer Res; 2015 Mar; 21(6):1457-65. PubMed ID: 25344580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.
    Zhang M; He Y; Sun X; Li Q; Wang W; Zhao A; Di W
    J Ovarian Res; 2014 Feb; 7():19. PubMed ID: 24507759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
    Ma J; Liu L; Che G; Yu N; Dai F; You Z
    BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
    Crotty EE; Smith SMC; Brasel K; Pakiam F; Girard EJ; Connor YD; Zindy F; Mhyre AJ; Roussel MF; Olson JM
    J Neurooncol; 2021 Jun; 153(2):225-237. PubMed ID: 33963961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophages (TAMs): clinical-pathological parameters in squamous cell carcinomas of the lower lip.
    Lúcio PS; Ribeiro DC; Aguiar MC; Alves PM; Nonaka CF; Godoy GP
    Braz Oral Res; 2016 Aug; 30(1):e95. PubMed ID: 27556682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High MUC2 expression in ovarian cancer is inversely associated with the M1/M2 ratio of tumor-associated macrophages and patient survival time.
    He YF; Zhang MY; Wu X; Sun XJ; Xu T; He QZ; Di W
    PLoS One; 2013; 8(12):e79769. PubMed ID: 24324582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast cancer cells educate macrophages toward the M2 activation status.
    Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
    Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of tumour-associated macrophages with poor prognosis in Wilms' tumour.
    Tian K; Wang X; Wu Y; Wu X; Du G; Liu W; Wu R
    J Pediatr Urol; 2020 Jun; 16(3):376.e1-376.e8. PubMed ID: 32299765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
    Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
    Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.
    Zaki MA; Wada N; Ikeda J; Shibayama H; Hashimoto K; Yamagami T; Tatsumi Y; Tsukaguchi M; Take H; Tsudo M; Morii E; Aozasa K
    Virchows Arch; 2011 Oct; 459(4):361-6. PubMed ID: 21874508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.